Literature DB >> 11795425

Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair.

J M Isner1, C Kalka, A Kawamoto, T Asahara.   

Abstract

Postnatal neovascularization has previously been considered synonymous with angiogenesis, but the finding that circulating endothelial progenitor cells (EPCs) may home to sites of neovascularization and there differentiate into endothelial cells (ECs) is consistent with "vasculogenesis," through which the primordial vascular network is established in the embryo. Our findings suggest that growth and development of new blood vessels in the adult are not restricted to angiogenesis but encompass vasculogenesis as well, although the proportional contributions remain to be clarified. Likewise, augmented or retarded neovascularization probably involves enhancement or impariment of the vasculogenesis process.

Entities:  

Mesh:

Year:  2001        PMID: 11795425     DOI: 10.1111/j.1749-6632.2001.tb02075.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  Molecular profiling of angiogenic markers: a step towards interpretive analysis of a complex biological function.

Authors:  Kevin P Claffey
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

2.  Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells.

Authors:  Sarah J Ohle; Asha Anandaiah; Attila J Fabian; Alan Fine; Darrell N Kotton
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-09       Impact factor: 6.914

3.  Monocytes form a vascular barrier and participate in vessel repair after brain injury.

Authors:  John Glod; David Kobiler; Martha Noel; Rajeth Koneru; Shoshana Lehrer; Daniel Medina; Dragan Maric; Howard A Fine
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

4.  Endothelial cell proliferation in the choriocapillaris during human retinal differentiation.

Authors:  A Allende; M C Madigan; J M Provis
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

5.  Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.

Authors:  Victoria Ulrich; Eddy S Konaniah; Wan-Ru Lee; Sadiksha Khadka; Yu-Min Shen; Joachim Herz; Jane E Salmon; David Y Hui; Philip W Shaul; Chieko Mineo
Journal:  J Am Heart Assoc       Date:  2014-10-14       Impact factor: 5.501

6.  Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.

Authors:  Takuji Torimura; Takato Ueno; Eitaro Taniguchi; Hiroshi Masuda; Hideki Iwamoto; Toru Nakamura; Kinya Inoue; Osamu Hashimoto; Mitsuhiko Abe; Hironori Koga; Vincenza Barresi; Emi Nakashima; Hirohisa Yano; Michio Sata
Journal:  Cancer Sci       Date:  2012-01-25       Impact factor: 6.716

7.  Preferential activity of Tie2 promoter in arteriolar endothelium.

Authors:  Mirela Anghelina; Leni Moldovan; Nicanor I Moldovan
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

8.  Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia.

Authors:  Xiangqian Hou; Xuejun Wu; Junxi Ma; Xinhui Lv; Xing Jin
Journal:  Mol Biol Rep       Date:  2009-05-12       Impact factor: 2.316

9.  Bone marrow transplantation transfers age-related susceptibility to neovascular remodeling in murine laser-induced choroidal neovascularization.

Authors:  Diego G Espinosa-Heidmann; Goldis Malek; Priyatham S Mettu; Alejandro Caicedo; Peter Saloupis; Sarah Gach; Askia K Dunnon; Peng Hu; Maria-Grazia Spiga; Scott W Cousins
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-13       Impact factor: 4.799

10.  The impact of bioactive lipids on cardiovascular development.

Authors:  Alexander Kleger; Stefan Liebau; Qiong Lin; Götz von Wichert; Thomas Seufferlein
Journal:  Stem Cells Int       Date:  2011-08-02       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.